Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective

Ewa Konduracka1, Grazyna Cieslik, Danuta Galicka-Latala

  • 1Department of Coronary Disease, Jagiellonian University School of Medicine, John Paul II Hospital, Prądnicka 80, 31-202, Krakow, Poland, ekonduracka@interia.eu.

Acta Diabetologica
|January 30, 2013
PubMed

Insights

Myocardial dysfunction and heart failure in long-term type 1 diabetes patients primarily occurred when coexisting with cardiovascular conditions like hypertension or coronary heart disease, with relatively low incidence rates observed.

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetology

Background:

  • Type 1 diabetes (T1D) is a chronic condition requiring long-term management.
  • Cardiovascular complications, including myocardial dysfunction (MD) and heart failure (HF), are significant concerns in T1D.
  • Understanding the prevalence and incidence of MD and HF in T1D, especially with coexisting cardiovascular disorders, is crucial for patient care.

Purpose of the Study:

  • To evaluate the prevalence and incidence of myocardial dysfunction (MD) and heart failure (HF) in patients with long-lasting type 1 diabetes (≥10 years).
  • To investigate the occurrence of MD and HF in T1D patients with and without cardiovascular disorders (hypertension, coronary heart disease - CHD).

Main Methods:

  • A cohort of 1,685 patients with type 1 diabetes (mean age 51, diabetes duration 36 years) was studied.
  • Echocardiography, NT-proBNP measurement, and clinical evaluation were performed at baseline.
  • A 7-year follow-up assessed systolic and diastolic MD and HF manifestations.

Main Results:

  • Overall HF prevalence was 3.7% and incidence 0.02%/year; MD prevalence was 14.5% (incidence -0.1%/year).
  • MD and HF were exclusively observed in patients with coexisting hypertension or CHD.
  • Baseline predictors for HF included age, diabetes duration, HbA1c, CHD, elevated systolic blood pressure, and reduced GFR.

Conclusions:

  • In type 1 diabetes, myocardial dysfunction and heart failure manifest primarily when associated with other cardiovascular disorders.
  • The prevalence and incidence of HF in T1D patients with hypertension and CHD were notably low.
  • Concomitant treatments may offer a cardioprotective effect, potentially explaining the low HF rates, though further research is needed.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...